The exploratory pre-seed program is a stimulus fund established to accelerate commercialization of biomedical research findings and development of novel technologies within the life sciences. The program seeks to support application-oriented research and to test new ideas that may lead to the development of new medical treatments, disease prevention, devices and diagnostic methods as well as new industrial biotechnology in the life science area. Deadline is October 16th.
For more information.